Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

Webinar on December 11 to feature leading KOLs in dermatology and hair loss alongside Absci leadershipPhase 1/2a trial now expected to begin in ...

All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the ...

The Kosmoderma Sarjapura clinic offers a full range of treatments, from laser hair removal and anti-ageing procedures to acne management and body contouring. All services are delivered under medical ...

Fungabeam Laser Device 2025 - Advanced low-level laser technology to eliminate nail fungus safely at home. Painless, chemical-free, and effective.

New longitudinal research reveals that severe stress caused by changes in family structure like divorce or separation experienced ...

BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...

Complete B cell depletion, rapid reduction in autoantibodies and near-complete resolution of clinical symptoms in two of three refractory patients; all three patients remained off immunomodulators sin ...

BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...

NORTHAMPTON, MA / ACCESS Newswire / October 15, 2025 / NCDs are the leading cause of death globally, representing a significant burden to people and health care systems. As many as 18 million people d ...

Digital Limelight Media, LLC has released an overview of the current medical marketing environment for 2025, addressing the ...